Which has stronger earnings & valuation, NVST or EYE?

Envista has higher revenue and earnings than National Vision. National Vision is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Envista $2.72B 1.52 $47M $0.41 61.78 National Vision $1.99B 0.68 $29.60M $0.57 29.44

Do analysts rate EYE or STVN?

National Vision presently has a consensus price target of $30.08, suggesting a potential upside of 79.28%. Given National Vision's higher probable upside, research analysts plainly believe National Vision is more favorable than Stevanato Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score National Vision 0 Sell rating(s) 5 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.58 Stevanato Group 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 2.86

Does the media refer more to EYE or STVN?

In the previous week, Stevanato Group had 3 more articles in the media than National Vision. MarketBeat recorded 4 mentions for Stevanato Group and 1 mentions for National Vision. National Vision's average media sentiment score of 1.02 beat Stevanato Group's score of 0.86 indicating that National Vision is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment National Vision 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Stevanato Group 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, LIVN or EYE?

National Vision has higher revenue and earnings than LivaNova. National Vision is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio LivaNova $1.39B 3.11 -$242.47M $1.95 40.35 National Vision $1.99B 0.68 $29.60M $0.57 29.44

Does the media favor LIVN or EYE?

In the previous week, LivaNova and LivaNova both had 1 articles in the media. LivaNova's average media sentiment score of 1.04 beat National Vision's score of 1.02 indicating that LivaNova is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LivaNova 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive National Vision 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, MMED or EYE?

National Vision has lower revenue, but higher earnings than MiniMed Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio MiniMed Group $2.99B 1.29 N/A N/A N/A National Vision $1.99B 0.68 $29.60M $0.57 29.44

Does the media refer more to MMED or EYE?

In the previous week, MiniMed Group had 1 more articles in the media than National Vision. MarketBeat recorded 2 mentions for MiniMed Group and 1 mentions for National Vision. National Vision's average media sentiment score of 1.02 beat MiniMed Group's score of 0.00 indicating that National Vision is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiniMed Group 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral National Vision 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

National Vision (EYE) Competitors

$16.78 -0.18 (-1.06%)

As of 06/23/2026 04:00 PM Eastern

Compare

EYE vs. NVST, BLCO, STVN, LIVN, and MMED

Should you buy National Vision stock or one of its competitors? MarketBeat compares National Vision with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with National Vision include Envista (NVST), Bausch + Lomb (BLCO), Stevanato Group (STVN), LivaNova (LIVN), and MiniMed Group (MMED). These companies are all part of the "medical equipment" industry.

How does National Vision compare to Envista?

Envista (NYSE:NVST) and National Vision (NASDAQ:EYE) are both medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, risk, valuation, media sentiment and analyst recommendations.

Envista has higher revenue and earnings than National Vision. National Vision is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.72B	1.52	$47M	$0.41	61.78
National Vision	$1.99B	0.68	$29.60M	$0.57	29.44

Envista has a net margin of 2.41% compared to National Vision's net margin of 2.31%. Envista's return on equity of 7.11% beat National Vision's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	2.41%	7.11%	3.91%
National Vision	2.31%	6.41%	2.81%

Envista has a beta of 0.88, suggesting that its share price is 12% less volatile than the broader market. Comparatively, National Vision has a beta of 1.07, suggesting that its share price is 7% more volatile than the broader market.

Envista presently has a consensus price target of $28.67, suggesting a potential upside of 13.17%. National Vision has a consensus price target of $30.08, suggesting a potential upside of 79.28%. Given National Vision's stronger consensus rating and higher possible upside, analysts clearly believe National Vision is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40
National Vision	0 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.58

In the previous week, National Vision had 1 more articles in the media than Envista. MarketBeat recorded 1 mentions for National Vision and 0 mentions for Envista. National Vision's average media sentiment score of 1.02 beat Envista's score of 0.89 indicating that National Vision is being referred to more favorably in the news media.

Company	Overall Sentiment
Envista	Positive
National Vision	Positive

Summary

Envista and National Vision tied by winning 7 of the 14 factors compared between the two stocks.

How does National Vision compare to Bausch + Lomb?

Bausch + Lomb (NYSE:BLCO) and National Vision (NASDAQ:EYE) are both medical equipment companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, media sentiment, risk, dividends and earnings.

In the previous week, National Vision had 1 more articles in the media than Bausch + Lomb. MarketBeat recorded 1 mentions for National Vision and 0 mentions for Bausch + Lomb. National Vision's average media sentiment score of 1.02 beat Bausch + Lomb's score of 0.98 indicating that National Vision is being referred to more favorably in the news media.

Company	Overall Sentiment
Bausch + Lomb	Positive
National Vision	Positive

Bausch + Lomb presently has a consensus target price of $17.92, suggesting a potential upside of 17.49%. National Vision has a consensus target price of $30.08, suggesting a potential upside of 79.28%. Given National Vision's stronger consensus rating and higher probable upside, analysts clearly believe National Vision is more favorable than Bausch + Lomb.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch + Lomb	1 Sell rating(s)	9 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.21
National Vision	0 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.58

National Vision has a net margin of 2.31% compared to Bausch + Lomb's net margin of -4.21%. National Vision's return on equity of 6.41% beat Bausch + Lomb's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bausch + Lomb	-4.21%	3.60%	1.69%
National Vision	2.31%	6.41%	2.81%

Bausch + Lomb has a beta of 0.58, meaning that its share price is 42% less volatile than the broader market. Comparatively, National Vision has a beta of 1.07, meaning that its share price is 7% more volatile than the broader market.

National Vision has lower revenue, but higher earnings than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch + Lomb	$5.10B	1.07	-$360M	-$0.62	N/A
National Vision	$1.99B	0.68	$29.60M	$0.57	29.44

11.1% of Bausch + Lomb shares are held by institutional investors. 1.5% of Bausch + Lomb shares are held by insiders. Comparatively, 2.4% of National Vision shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

National Vision beats Bausch + Lomb on 13 of the 16 factors compared between the two stocks.

How does National Vision compare to Stevanato Group?

National Vision (NASDAQ:EYE) and Stevanato Group (NYSE:STVN) are both medical equipment companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, media sentiment, institutional ownership, earnings, profitability and dividends.

Stevanato Group has a net margin of 11.76% compared to National Vision's net margin of 2.31%. Stevanato Group's return on equity of 10.27% beat National Vision's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
National Vision	2.31%	6.41%	2.81%
Stevanato Group	11.76%	10.27%	6.08%

Stevanato Group has lower revenue, but higher earnings than National Vision. Stevanato Group is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
National Vision	$1.99B	0.68	$29.60M	$0.57	29.44
Stevanato Group	€1.34B	3.79	€158.21M	€0.59	28.46

National Vision presently has a consensus price target of $30.08, suggesting a potential upside of 79.28%. Given National Vision's higher probable upside, research analysts plainly believe National Vision is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
National Vision	0 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.58
Stevanato Group	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	2 Strong Buy rating(s)	2.86

In the previous week, Stevanato Group had 3 more articles in the media than National Vision. MarketBeat recorded 4 mentions for Stevanato Group and 1 mentions for National Vision. National Vision's average media sentiment score of 1.02 beat Stevanato Group's score of 0.86 indicating that National Vision is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
National Vision	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Stevanato Group	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

National Vision has a beta of 1.07, suggesting that its stock price is 7% more volatile than the broader market. Comparatively, Stevanato Group has a beta of 0.78, suggesting that its stock price is 22% less volatile than the broader market.

Summary

Stevanato Group beats National Vision on 9 of the 15 factors compared between the two stocks.

How does National Vision compare to LivaNova?

LivaNova (NASDAQ:LIVN) and National Vision (NASDAQ:EYE) are both medical equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, earnings, media sentiment, dividends, valuation and profitability.

National Vision has higher revenue and earnings than LivaNova. National Vision is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LivaNova	$1.39B	3.11	-$242.47M	$1.95	40.35
National Vision	$1.99B	0.68	$29.60M	$0.57	29.44

In the previous week, LivaNova and LivaNova both had 1 articles in the media. LivaNova's average media sentiment score of 1.04 beat National Vision's score of 1.02 indicating that LivaNova is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LivaNova	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
National Vision	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

97.6% of LivaNova shares are held by institutional investors. 0.4% of LivaNova shares are held by insiders. Comparatively, 2.4% of National Vision shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

LivaNova presently has a consensus target price of $80.75, suggesting a potential upside of 2.63%. National Vision has a consensus target price of $30.08, suggesting a potential upside of 79.28%. Given National Vision's higher possible upside, analysts plainly believe National Vision is more favorable than LivaNova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LivaNova	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.67
National Vision	0 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.58

LivaNova has a beta of 0.88, indicating that its stock price is 12% less volatile than the broader market. Comparatively, National Vision has a beta of 1.07, indicating that its stock price is 7% more volatile than the broader market.

LivaNova has a net margin of 7.48% compared to National Vision's net margin of 2.31%. LivaNova's return on equity of 16.48% beat National Vision's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LivaNova	7.48%	16.48%	7.59%
National Vision	2.31%	6.41%	2.81%

Summary

LivaNova beats National Vision on 9 of the 15 factors compared between the two stocks.

How does National Vision compare to MiniMed Group?

MiniMed Group (NASDAQ:MMED) and National Vision (NASDAQ:EYE) are both medical equipment companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability.

In the previous week, MiniMed Group had 1 more articles in the media than National Vision. MarketBeat recorded 2 mentions for MiniMed Group and 1 mentions for National Vision. National Vision's average media sentiment score of 1.02 beat MiniMed Group's score of 0.00 indicating that National Vision is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiniMed Group	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
National Vision	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

MiniMed Group currently has a consensus price target of $21.33, suggesting a potential upside of 55.26%. National Vision has a consensus price target of $30.08, suggesting a potential upside of 79.28%. Given National Vision's higher probable upside, analysts plainly believe National Vision is more favorable than MiniMed Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.73
National Vision	0 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.58

National Vision has lower revenue, but higher earnings than MiniMed Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiniMed Group	$2.99B	1.29	N/A	N/A	N/A
National Vision	$1.99B	0.68	$29.60M	$0.57	29.44

National Vision has a net margin of 2.31% compared to MiniMed Group's net margin of 0.00%. National Vision's return on equity of 6.41% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiniMed Group	N/A	N/A	N/A
National Vision	2.31%	6.41%	2.81%

19.7% of MiniMed Group shares are held by institutional investors. 2.2% of MiniMed Group shares are held by company insiders. Comparatively, 2.4% of National Vision shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

MiniMed Group and National Vision tied by winning 6 of the 12 factors compared between the two stocks.

Get National Vision News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EYE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EYE vs. The Competition

Export

Metric	National Vision	CONS PD Industry	Staples Sector	NASDAQ Exchange
Market Cap	$1.36B	$29.83B	$16.02B	$12.39B
Dividend Yield	N/A	3.29%	3.56%	5.83%
P/E Ratio	29.44	72.46	25.58	23.98
Price / Sales	0.68	1.58	47.14	109.07
Price / Cash	9.47	31.30	16.29	54.51
Price / Book	1.53	10.90	5.80	6.50
Net Income	$29.60M	$1.30B	$678.29M	$336.88M
7 Day Performance	2.94%	-1.03%	0.23%	-0.14%
1 Month Performance	-2.04%	12.00%	0.93%	0.77%
1 Year Performance	-27.33%	-13.26%	-12.02%	28.49%

National Vision Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EYE National Vision	3.9936 of 5 stars	$16.78 -1.1%	$30.08 +79.3%	-26.0%	$1.36B	$1.99B	29.44	13,138	Positive News
NVST Envista	2.358 of 5 stars	$24.63 -0.2%	$28.67 +16.4%	+34.0%	$4.02B	$2.72B	60.22	12,000
BLCO Bausch + Lomb	3.5022 of 5 stars	$15.13 +0.9%	$17.92 +18.4%	+27.0%	$5.36B	$5.10B	N/A	13,000
STVN Stevanato Group	3.3408 of 5 stars	€16.85 +1.3%	N/A	-28.9%	€5.17B	€1.34B	28.93	6,010
LIVN LivaNova	2.1785 of 5 stars	$80.01 +0.4%	$79.38 -0.8%	+72.7%	$4.40B	$1.39B	41.10	3,300	Positive News Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:EYE) was last updated on 6/24/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

National Vision (EYE) Competitors

EYE vs. NVST, BLCO, STVN, LIVN, and MMED

How does National Vision compare to Envista?

Summary

How does National Vision compare to Bausch + Lomb?

Summary

How does National Vision compare to Stevanato Group?

Summary

How does National Vision compare to LivaNova?

Summary

How does National Vision compare to MiniMed Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EYE vs. The Competition

National Vision Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

National Vision (EYE) Competitors

EYE vs. NVST, BLCO, STVN, LIVN, and MMED

How does National Vision compare to Envista?

Which has stronger earnings & valuation, NVST or EYE?

Is NVST or EYE more profitable?

Which has more risk and volatility, NVST or EYE?

Do analysts prefer NVST or EYE?

Does the media refer more to NVST or EYE?

Summary

How does National Vision compare to Bausch + Lomb?

Does the media refer more to BLCO or EYE?

Do analysts prefer BLCO or EYE?

Is BLCO or EYE more profitable?

Which has more volatility & risk, BLCO or EYE?

Which has higher valuation and earnings, BLCO or EYE?

Do institutionals and insiders believe in BLCO or EYE?

Summary

How does National Vision compare to Stevanato Group?

Is EYE or STVN more profitable?

Which has stronger valuation & earnings, EYE or STVN?

Do analysts rate EYE or STVN?

Does the media refer more to EYE or STVN?

Which has more volatility & risk, EYE or STVN?

Summary

How does National Vision compare to LivaNova?

Which has preferable valuation and earnings, LIVN or EYE?

Does the media favor LIVN or EYE?

Do insiders & institutionals believe in LIVN or EYE?

Do analysts rate LIVN or EYE?

Which has more risk and volatility, LIVN or EYE?

Is LIVN or EYE more profitable?

Summary

How does National Vision compare to MiniMed Group?

Does the media refer more to MMED or EYE?

Do analysts recommend MMED or EYE?

Which has stronger earnings & valuation, MMED or EYE?

Is MMED or EYE more profitable?

Do insiders and institutionals believe in MMED or EYE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EYE vs. The Competition

National Vision Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools